From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's diseaseTalita P.C. Chierrito, Ivone Carvalho, Ana Martı́nez et al.|European Journal of Medicinal Chemistry|2017Cited by 54